Price Review of Stock:: Walgreens Boots Alliance, Inc. (WBA)

Xavier Trudeau
Août 18, 2017

The fund owned 187,772 shares of the pharmacy operator's stock after selling 12,525 shares during the period. Isthmus Partners LLC's holdings in Walgreens Boots Alliance were worth $805,000 as of its most recent filing with the SEC. Burke & Herbert Bank & Trust Co. bought a new position in shares of Walgreens Boots Alliance during the first quarter valued at $270,000. (WBA) has a market capitalization of 86.82 Billion which suggests the company is a huge company further suggesting that the shares of Walgreens Boots Alliance, Inc. UBS Asset Management Americas Inc. now owns 4,912,489 shares of the pharmacy operator's stock valued at $407,982,000 after buying an additional 914,888 shares during the period.

With all other things going on, Walgreens Boots Alliance, Inc. Howe & Rusling Inc. now owns 1,441 shares of the pharmacy operator's stock worth $120,000 after buying an additional 975 shares in the last quarter.

For this year, Walgreens Boots Alliance, Inc. Canada Pension Plan Investment Board now owns 1,982,013 shares of the pharmacy operator's stock valued at $164,606,000 after buying an additional 444,900 shares during the period. Walgreens Boots Alliance, Inc. has a one year low of $75.18 and a one year high of $88.00. (NASDAQ WBA) traded down 0.46% during midday trading on Thursday, reaching $80.89. Continues to Hold Stake in Walgreens Boots Alliance, Inc. Moving averages are considered to be lagging indicators that simply take the average price of a stock over a certain period of time.

Therefore, ROE for Walgreens Boots Alliance, Inc., WBA is 14.40%. The pharmacy operator reported $1.33 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. (WBA). The consensus rating is 2, indicating analysts in general look favorably on the company's future prospects. During the same period in the prior year, the business posted $1.18 earnings per share. (NASDAQ:WBA), at its latest closing price of $80.89, it has a price-to-book ratio of 2.84, compared to an industry average at 2.85. On average, equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 12th. Investors of record on Friday, August 18th will be issued a dividend of $0.40 per share. (WBA) has an annual dividend of $1.6, while its annual dividend yield is 1.96%. The ex-dividend date is Wednesday, August 16th. This is a positive change from Walgreens Boots Alliance's previous quarterly dividend of $0.38. Walgreens Boots Alliance's dividend payout ratio is now 37.78%. Stock buyback plans are typically a sign that the company's board of directors believes its shares are undervalued. Finally, Citigroup Inc. reissued a "buy" rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Guggenheim reaffirmed a "buy" rating on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. They now have a Dollars 86 price target on the stock. Finally, Goldman Sachs Group, Inc. Leerink Swann fixed a $86.00 target price on Walgreens Boots Alliance and issued the company a "buy" recommendation in a analysis report on Friday morning, Jul 7th.

A number of equities analysts recently commented on the stock. The company has an average rating of "Buy" and an average price target of $90.69.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the company's stock in a transaction that occurred on Tuesday, July 25th. According to Thomson Reuters, sell-side analysts are forecasting a harmony target price of $93.00 on company shares. Institutional investors own 62.9% stake in the company while Beta factor, which is used to measure riskiness of the security, was 1.26. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The corporation had a trading volume of 1,357,511 Stocks. The legal version of this article can be viewed at The corporation is a global pharmacy-led, health and wellbeing enterprise. The Firm operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale.

D'autres rapports CampDesrEcrues

Discuter de cet article